Last updated 9 days ago
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
1200 patients around the world
Available in Puerto Rico, Chile, United States, Argentina
Merck Sharp & Dohme LLC
10Research sites
1200Patients around the world
This study is for people with
Prostate cancer
Metastatic prostate cancer
Requirements for the patient
All Gender
Medical requirements
Sites
Hospital Británico de Buenos Aires - CABA
Recruiting
Hospital Asociación de Beneficencia Hospital Sirio Libanes - CABA, Buenos Aires
Recruiting
Instituto de Investigaciones Clínicas Mar del Plata
Recruiting
Centro Oncológico de Integración Regional C.O.I.R.
Recruiting
Hospital Alemán
Recruiting
Sanatorio Parque - Rosario
Recruiting
Instituto Médico Especializado Alexander Fleming - CABA, Buenos Aires
Recruiting
Centro de Investigación Clínica Bradford Hill - Santiago, Región Metropolitana
Recruiting
Clinical Research Chile SpA
Recruiting
IC La Serena Research - La Serena
Recruiting
StudyMK-5684-003
SponsorMerck Sharp & Dohme LLC
Conditions
Metastatic prostate cancer
Requirements
All Gender
Unique study IDclinicaltrials.gov
NCT06136624
